Copyright Reports & Markets. All rights reserved.

Global Stem Cell Therapy for Osteoarthritis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Stem Cell Therapy for Osteoarthritis by Type
    • 1.3.1 Overview: Global Stem Cell Therapy for Osteoarthritis Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Stem Cell Therapy for Osteoarthritis Consumption Value Market Share by Type in 2023
    • 1.3.3 Fat Cell
    • 1.3.4 Bone Marrow Cell
    • 1.3.5 Others
  • 1.4 Global Stem Cell Therapy for Osteoarthritis Market by Application
    • 1.4.1 Overview: Global Stem Cell Therapy for Osteoarthritis Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Primary Osteoarthritis
    • 1.4.3 Secondary Osteoarthritis
  • 1.5 Global Stem Cell Therapy for Osteoarthritis Market Size & Forecast
  • 1.6 Global Stem Cell Therapy for Osteoarthritis Market Size and Forecast by Region
    • 1.6.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Region, (2019-2030)
    • 1.6.3 North America Stem Cell Therapy for Osteoarthritis Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Stem Cell Therapy for Osteoarthritis Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size and Prospect (2019-2030)
    • 1.6.6 South America Stem Cell Therapy for Osteoarthritis Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Medipost
    • 2.1.1 Medipost Details
    • 2.1.2 Medipost Major Business
    • 2.1.3 Medipost Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.1.4 Medipost Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Medipost Recent Developments and Future Plans
  • 2.2 Theracell Advanced Biotechnology
    • 2.2.1 Theracell Advanced Biotechnology Details
    • 2.2.2 Theracell Advanced Biotechnology Major Business
    • 2.2.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.2.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Theracell Advanced Biotechnology Recent Developments and Future Plans
  • 2.3 Nature Cell
    • 2.3.1 Nature Cell Details
    • 2.3.2 Nature Cell Major Business
    • 2.3.3 Nature Cell Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.3.4 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Nature Cell Recent Developments and Future Plans
  • 2.4 Stempeutics
    • 2.4.1 Stempeutics Details
    • 2.4.2 Stempeutics Major Business
    • 2.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.4.4 Stempeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Stempeutics Recent Developments and Future Plans
  • 2.5 Regeneus
    • 2.5.1 Regeneus Details
    • 2.5.2 Regeneus Major Business
    • 2.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.5.4 Regeneus Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Regeneus Recent Developments and Future Plans
  • 2.6 Xintela AB
    • 2.6.1 Xintela AB Details
    • 2.6.2 Xintela AB Major Business
    • 2.6.3 Xintela AB Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.6.4 Xintela AB Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Xintela AB Recent Developments and Future Plans
  • 2.7 Cells for Cells
    • 2.7.1 Cells for Cells Details
    • 2.7.2 Cells for Cells Major Business
    • 2.7.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.7.4 Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Cells for Cells Recent Developments and Future Plans
  • 2.8 CellTex Therapeutics
    • 2.8.1 CellTex Therapeutics Details
    • 2.8.2 CellTex Therapeutics Major Business
    • 2.8.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.8.4 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 CellTex Therapeutics Recent Developments and Future Plans
  • 2.9 UCI Health
    • 2.9.1 UCI Health Details
    • 2.9.2 UCI Health Major Business
    • 2.9.3 UCI Health Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.9.4 UCI Health Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 UCI Health Recent Developments and Future Plans
  • 2.10 Magellan
    • 2.10.1 Magellan Details
    • 2.10.2 Magellan Major Business
    • 2.10.3 Magellan Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.10.4 Magellan Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Magellan Recent Developments and Future Plans
  • 2.11 AbelZeta Pharma
    • 2.11.1 AbelZeta Pharma Details
    • 2.11.2 AbelZeta Pharma Major Business
    • 2.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product and Solutions
    • 2.11.4 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 AbelZeta Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Stem Cell Therapy for Osteoarthritis Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Stem Cell Therapy for Osteoarthritis by Company Revenue
    • 3.2.2 Top 3 Stem Cell Therapy for Osteoarthritis Players Market Share in 2023
    • 3.2.3 Top 6 Stem Cell Therapy for Osteoarthritis Players Market Share in 2023
  • 3.3 Stem Cell Therapy for Osteoarthritis Market: Overall Company Footprint Analysis
    • 3.3.1 Stem Cell Therapy for Osteoarthritis Market: Region Footprint
    • 3.3.2 Stem Cell Therapy for Osteoarthritis Market: Company Product Type Footprint
    • 3.3.3 Stem Cell Therapy for Osteoarthritis Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Stem Cell Therapy for Osteoarthritis Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Stem Cell Therapy for Osteoarthritis Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Stem Cell Therapy for Osteoarthritis Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Stem Cell Therapy for Osteoarthritis Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Stem Cell Therapy for Osteoarthritis Consumption Value by Type (2019-2030)
  • 6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2030)
  • 6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 6.3.1 North America Stem Cell Therapy for Osteoarthritis Consumption Value by Country (2019-2030)
    • 6.3.2 United States Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Stem Cell Therapy for Osteoarthritis Consumption Value by Type (2019-2030)
  • 7.2 Europe Stem Cell Therapy for Osteoarthritis Consumption Value by Application (2019-2030)
  • 7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 7.3.1 Europe Stem Cell Therapy for Osteoarthritis Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 7.3.3 France Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region
    • 8.3.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Consumption Value by Region (2019-2030)
    • 8.3.2 China Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 8.3.5 India Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Stem Cell Therapy for Osteoarthritis Consumption Value by Type (2019-2030)
  • 9.2 South America Stem Cell Therapy for Osteoarthritis Consumption Value by Application (2019-2030)
  • 9.3 South America Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 9.3.1 South America Stem Cell Therapy for Osteoarthritis Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 10.3.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Stem Cell Therapy for Osteoarthritis Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Stem Cell Therapy for Osteoarthritis Market Drivers
  • 11.2 Stem Cell Therapy for Osteoarthritis Market Restraints
  • 11.3 Stem Cell Therapy for Osteoarthritis Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Stem Cell Therapy for Osteoarthritis Industry Chain
  • 12.2 Stem Cell Therapy for Osteoarthritis Upstream Analysis
  • 12.3 Stem Cell Therapy for Osteoarthritis Midstream Analysis
  • 12.4 Stem Cell Therapy for Osteoarthritis Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.
    Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
    According to our (Global Info Research) latest study, the global Stem Cell Therapy for Osteoarthritis market size was valued at US$ 33.8 million in 2023 and is forecast to a readjusted size of USD 201 million by 2030 with a CAGR of 29.2% during review period.
    The key players of Stem Cell Therapy for Osteoarthritis include Medipost, Theracell Advanced Biotechnology, Nature Cell and Stempeutics. The top 2 manufacturers hold approximately 84% of the global market share.
    In terms of product type, Fat Cell is the largest segment, with a share of 94%. And in terms of application, Primary Osteoarthritis has a share about 91 percent.

    This report is a detailed and comprehensive analysis for global Stem Cell Therapy for Osteoarthritis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Stem Cell Therapy for Osteoarthritis market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Stem Cell Therapy for Osteoarthritis market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Stem Cell Therapy for Osteoarthritis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Stem Cell Therapy for Osteoarthritis market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Stem Cell Therapy for Osteoarthritis
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Stem Cell Therapy for Osteoarthritis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medipost, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Regeneus, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Stem Cell Therapy for Osteoarthritis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Stem Cell Therapy for Osteoarthritis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Fat Cell
    Bone Marrow Cell
    Others
    Market segment by Application
    Primary Osteoarthritis
    Secondary Osteoarthritis
    Market segment by players, this report covers
    Medipost
    Theracell Advanced Biotechnology
    Nature Cell
    Stempeutics
    Regeneus
    Xintela AB
    Cells for Cells
    CellTex Therapeutics
    UCI Health
    Magellan
    AbelZeta Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Stem Cell Therapy for Osteoarthritis product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Stem Cell Therapy for Osteoarthritis, with revenue, gross margin, and global market share of Stem Cell Therapy for Osteoarthritis from 2019 to 2024.
    Chapter 3, the Stem Cell Therapy for Osteoarthritis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Stem Cell Therapy for Osteoarthritis market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Stem Cell Therapy for Osteoarthritis.
    Chapter 13, to describe Stem Cell Therapy for Osteoarthritis research findings and conclusion.

    Buy now